AlphaCrest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$573K Buy
2022
Q2
$152K Sell
2022
Q1
$1.25M Buy
2021
Q4
$406K Sell
2021
Q3
$1.11M Buy
2021
Q2
$1.34M Buy
2021
Q1
$1.06M Buy
2020
Q4
$494K Buy
2020
Q3
Sell
2020
Q2
$302K Sell
2020
Q1
$975K Buy
2019
Q4
$455K Buy
2019
Q3
$277K Buy